Data analytics and evidence synthesis to inform health policy and practice

Data analytics and evidence synthesis to inform health policy and practice

Large-scale data analytics is the science of using a range of data types to inform community, practitioner and policy-maker decision-making. In the population health context, data types include routinely collected data (e.g. hospitalisation, cancer registry and death data) and cohort studies, or separate efforts such as quality registries. Analyses are conducted to quantify the role of modifiable risk factors for health conditions, to fill the gaps identified in major evidence assessments such as health technology assessments, guidelines and other reviews and to interpret patient data for a more people-centred integrated care approach in healthcare and implementation sciences. Both large data analytics and evidence synthesis help link between research and practice


Academic staff

Professional staff



Filter by keyword
Project Status
(S)WASH-D for WORMS Current
A Pilot Randomised Controlled Trial of Implementation of ‘The Patient Enablement Model’     Current
A systematic review of the literature examining the relative efficacy of peridischarge strategies to reduce unplanned 30-day readmission rates after knee and hip arthroplasty Current
AADRF Current
Absolute Cardiovascular Disease (CVD) risk and implementation Current
Ageing in China and Australia: Promoting health, productivity and wellbeing Current
Assessing mental health Current
Building capacity for evidence-based health development in Indonesia Current
Cancer survivorship Potential
Cardiovascular Disease - Risk Factors, Care, Incidence, Outcome (disability, income, work status) Potential
Censoring rates in survival analysis Potential
Centre of Research Excellence in Medicines and Ageing (CREMA) Current
Chronic disease and healthy ageing for Aboriginal and Torres Strait Islander people, including tobacco Current
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) Current
Combined effect of statins and blood-pressure-lowering medications in people without established cardiovascular disease: a meta-analysis of RCTs. Potential
Conquering schistosomiasis in China – the last mile (QIMR) Current
CVD risk, prevention and implementation Current
Death prediction modelling Current
Developing technologies to support patients’ transition from acute to primary care: enabling orthopaedic patients and preventing unplanned 30-day readmissions.    Current
Diagnostics in generalised linear mixed models Potential
Dust storms, drought and spatio-temporal patterns in respiratory mortality Current
Environmental change and the spread of diseases from animals to humans Current
Epidemiology of suicidal behaviour Current
Getting real about risk: using patient medical records for the geospatial analysis of chronic diseases Current
Health impacts of tobacco Potential
Health of Aboriginal and Torres Strait Islander Children Potential
Information criteria in survival analysis Potential
Large-scale data to improve Aboriginal child health: seeding success and beyond Current
Latitudinal gradients in disease Current
Lifestyle influences of healthy ageing and chronic disease: Longitudinal predictors Current
Measuring perinatal mortality through triangulation of data from various sources in selected districts of Indonesia Potential
Medical students' attitudes to people who use drugs Potential
Medications - Patterns of utilisation, Psychoactive drugs, CVD preventative medications Potential
Meta-analysis of factors affecting adherence to lipid-lowering and blood-pressure-lowering pharmacotherapies for the primary prevention of cardiovascular disease. Potential
Missing data in multilevel models Current
Multiple Sclerosis Vitamin D Metabolites Study Current
New uses of meta-analysis Potential
Pharmaceutical opioid use and related adverse outcome among older Australians Current
Pharmacoepidemiology and chronic disease Current
PhoCIS Study (led at Telethon Kids Institute) Current
Predictors of hospital discharge to home following four main surgeries Current
PrevANZ Study (led at University of Melbourne) Current
Productive Ageing in Australia and Asia Current
Quality and Efficiency in Laboratory Medicine and Pathology Current
Reducing family violence among Aboriginal and Torres Strait Islander communities Current
Risk factors and mortality in the Thai Cohort Study Potential
Small area estimation of health outcomes Potential
Small area estimation of health outcomes Potential
Smoking among Aboriginal and Torres Strait Islander adults: health impacts, associated factors, and trends over time Current
Smoking and health: large scale data on important outcomes Current
Social engagement and workforce participation among cancer survivors. Potential
Social fragmentation and mental disorders Current
Socioeconomic determinants of health and wellbeing across the life course: Australian and English comparisons Current
Socioeconomic inequalities in the utilisation of cardiac procedures following major cardiovascular disease events. Potential
Spatio-temporal modelling of infections associated with antibiotic use (e.g MRSA, Clostridium difficile) Current
Study of Environment on Aboriginal Resilience and Child Health Current
Thai Health-Risk Transition Project Current
The Ausimmune and AusLong Studies Current
The effectiveness, acceptability and cost effectiveness of the 'BALatrine' Current
Variation in CVD risk, incidence, care and outcomes Current
Variation in fatal burden of disease, preventive CVD care and end-of-life care Current
Variations in Health Service Use Potential

Updated:  21 September 2017/Responsible Officer:  Director/Page Contact:  Executive Support Officer